about
Defining the publication source of high-quality evidence in urology: an analysis of EvidenceUpdates.The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer.The Effects of Beginning Population Based PSA Screening at Age 40.Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice.The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.Improved Reporting of Randomized Controlled Trials in the Urologic Literature.Re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811-9.Re: Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression: S. R. Shim, K. J. Kanhai, Y. M. Ko and J. H. Kim J Urol 2017;197:465-479.A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer.Racial disparities and considerations for active surveillance of prostate cancer.Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid ReviewThe fragility of statistically significant findings from randomised controlled trials in the urological literatureEarly Stage Cancer in Older Adults: Prostate-Avoiding Overtreatment and UndertreatmentEvaluating Region of Interest Measurement Strategies to Characterize Upper Urinary Tract Stones on Computerized TomographyTCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancerThe Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive TrialThe impact of squamous histology on survival in patients with muscle-invasive bladder cancerBladder changes after catheterizable channel creation in adults with cerebral palsy who are in chronic urinary retentionThe History of Urology at the Minneapolis Veterans Affairs Health Care SystemGenomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant HistologyA critical appraisal of biomarkers in prostate cancer
P50
Q35867955-904DAD8C-5763-4006-A726-6FC42AB09C65Q38599334-3BEF78C7-A189-49B5-995F-07D6846112D2Q38607830-D54E1F3E-BAB9-48E7-9F51-43C692660CB6Q38874800-F29BF7F9-BFB5-4751-A2AD-7616545C9B73Q39406932-D286FD61-A6BE-4C11-A899-F407361C6630Q39509582-E59D3362-C6CF-4252-9C94-02EDDC7AC9F4Q47909341-C8E290C2-D0AF-46ED-B073-7DBBAFCBC390Q47928565-17CC4028-ED75-4DB1-AF63-FC8481E17B2EQ53834783-5FEEB1FB-ED21-4247-A693-F57893614F10Q55360389-4E0D3CD1-3005-47B4-BD44-97591836C76CQ57688989-4C0661E3-5595-4304-AD66-E70612AD7344Q88143003-B927BE28-BED8-4C76-9D32-37FCEF6E6E83Q88576131-56392617-9A76-4709-BE9C-3FCD3EB395E8Q88997088-A37FB5D3-EE52-41DE-AF8E-C28924D4D912Q89982532-0232ED5A-65B4-4C84-8DFD-082D158D64CEQ90000462-292EA07C-7E5D-4DB9-A174-01366BE8F4E8Q91296261-1BDC036F-2658-45E0-B28D-D0D8EAC79561Q91688178-545AC317-B2A5-46D7-9343-20D44C39F376Q91689872-283C25DC-694E-4C60-890E-55C2BDAA5972Q93022514-284FD7D3-1145-40E8-8135-DFB76EE742ECQ93143783-14A9ECAF-39C8-45FD-9136-B87B29BBF9F1
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Vikram M Narayan
@ast
Vikram M Narayan
@en
Vikram M Narayan
@es
Vikram M Narayan
@nl
type
label
Vikram M Narayan
@ast
Vikram M Narayan
@en
Vikram M Narayan
@es
Vikram M Narayan
@nl
prefLabel
Vikram M Narayan
@ast
Vikram M Narayan
@en
Vikram M Narayan
@es
Vikram M Narayan
@nl
P1153
57044383700
P31
P496
0000-0003-3731-4209